Soleno Therapeutics Inc (SLNO)
46.22
+0.32
(+0.70%)
USD |
NASDAQ |
Jan 07, 16:00
46.28
+0.06
(+0.13%)
After-Hours: 20:00
Soleno Therapeutics Shareholders Equity (Quarterly): 264.70M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Alnylam Pharmaceuticals Inc | 32.35M |
| Vertex Pharmaceuticals Inc | 15.63B |
| PTC Therapeutics Inc | -1.054B |
| Kronos Bio Inc | 111.13M |
| CEL-SCI Corp | 8.473M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 296.71M |
| Total Liabilities (Quarterly) | 32.01M |